Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · IEX Real-Time Price · USD
0.448
+0.004 (0.90%)
At close: Apr 24, 2024, 4:00 PM
0.458
+0.010 (2.32%)
After-hours: Apr 24, 2024, 7:41 PM EDT
Evoke Pharma Market Cap
Evoke Pharma has a market cap or net worth of $3.79 million as of April 25, 2024. Its market cap has decreased by -41.63% in one year.
Market Cap
3.79M
Enterprise Value
4.05M
1-Year Change
-41.63%
Ranking
Category
Stock Price
$0.45
Market Cap Chart
Since September 25, 2013, Evoke Pharma's market cap has decreased from $67.90M to $3.79M, a decrease of -94.41%. That is a compound annual growth rate of -23.86%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 3.80M | -2.56% |
Apr 22, 2024 | 3.90M | -2.50% |
Apr 19, 2024 | 4.00M | -2.44% |
Apr 18, 2024 | 4.10M | -12.77% |
Apr 17, 2024 | 4.70M | 17.50% |
Apr 16, 2024 | 4.00M | - |
Apr 15, 2024 | 4.00M | -6.98% |
Apr 12, 2024 | 4.30M | -6.52% |
Apr 11, 2024 | 4.60M | -6.12% |
Apr 10, 2024 | 4.90M | 8.89% |
Apr 9, 2024 | 4.50M | -4.26% |
Apr 8, 2024 | 4.70M | -6.00% |
Apr 5, 2024 | 5.00M | -1.96% |
Apr 4, 2024 | 5.10M | -3.77% |
Apr 3, 2024 | 5.30M | 1.92% |
Apr 2, 2024 | 5.20M | 4.00% |
Apr 1, 2024 | 5.00M | -3.85% |
Mar 28, 2024 | 5.20M | 4.00% |
Mar 27, 2024 | 5.00M | -1.96% |
Mar 26, 2024 | 5.10M | 2.00% |
Mar 25, 2024 | 5.00M | -1.96% |
Mar 22, 2024 | 5.10M | 2.00% |
Mar 21, 2024 | 5.00M | - |
Mar 20, 2024 | 5.00M | -3.85% |
Mar 19, 2024 | 5.20M | -1.89% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Artelo Biosciences | 4.20M |
Genprex | 4.13M |
ReShape Lifesciences | 3.91M |
Aethlon Medical | 3.88M |
Virpax Pharmaceuticals | 3.87M |
Phio Pharmaceuticals | 3.81M |
Clearmind Medicine | 3.77M |
Finch Therapeutics Group | 3.71M |